[Expression and glycosylation of rotavirus strain SA11 VP4 protein in a recombinant adenovirus].
Min Sun, Y Zhang, Yue Ma, Guohui Zhang, Qin Du, Chunhua Dai
Abstract
Min Sun, Y Zhang, Yue Ma, Guohui Zhang, Qin Du, Chunhua Dai
Abstract
OBJECTIVE: A modified VP4 gene of rotavirus SA11 strain was expressed by a recombinant human adenovirus. METHODS: A whole VP4 gene was obtained with PCR and induced the signal peptide at the gene N terminal. The chimera gene was cloned into pCMV plasmid that consist of human cytomagolovirus promoter and then cloned the gene to transfer human adenovirus type 5 vector. Homologues recombinant was performed by co-transfection to 293 cell line with recombinant plasmid and viral genome using CaPO4 precipitation. RESULTS: VP4 gene is 2,362 base pair in length mutation was not found in whole VP4 gene sequence. Expressed product in recombinant adnovirus was confirmed to be specific and more antigenicity by indirect immunofluorescence assay. Both Western blot and immunoprecipitation assays showed that expressed protein molecular weight was higher than wild type VP4 protein and that modified product was corresponding to a glycosylation of VP4 protein. CONCLUSIONS: It may be a effective method to modify interested gene for enhancing stability, antigenicity and immunogenicity of expressive product.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: A modified VP4 gene of rotavirus SA11 strain was expressed by a recombinant human adenovirus. METHODS: A whole VP4 gene was obtained with PCR and induced the signal peptide at the gene N terminal. The chimera gene was cloned into pCMV plasmid that consist of human cytomagolovirus promoter and then cloned the gene to transfer human adenovirus type 5 vector. Homologues recombinant was performed by co-transfection to 293 cell line with recombinant plasmid and viral genome using CaPO4 precipitation. RESULTS: VP4 gene is 2,362 base pair in length mutation was not found in whole VP4 gene sequence. Expressed product in recombinant adnovirus was confirmed to be specific and more antigenicity by indirect immunofluorescence assay. Both Western blot and immunoprecipitation assays showed that expressed protein molecular weight was higher than wild type VP4 protein and that modified product was corresponding to a glycosylation of VP4 protein. CONCLUSIONS: It may be a effective method to modify interested gene for enhancing stability, antigenicity and immunogenicity of expressive product.
Key concepts: Recombinant DNA, Molecular biology, Antigenicity, Biology, Gene, Plasmid, Virology, Gene product